If you are looking for specific information,please visit our country/region website.
GO TO NEWSROOM
TSE Code 4502TSE 1st
Improving Access to Healthcare in Remote Communities
IR Seminar for Investors and Analysts on Takeda’s Japan Oncology Business and its oncology products and disease in Japan
Information for US Patients Regarding the NATPARA Recall in the US
Offer for Shire plc
Copyright 1995-2021 Takeda Pharmaceutical Company Limited. All rights reserved.